From the Journals

Oral tecovirimat for smallpox shows efficacy in animals, safety in humans


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

Dr. Grosenbach and his coauthors reported a disclosure related to Biomedical Advanced Research and Development Authority (BARDA), grants from NIH during the conduct of the study, and personal fees from SIGA Technologies outside the submitted work.

SOURCE: Grosenbach DW et al. N Engl J Med. 2018 Jul 5;379(1):44-53.

Pages

Recommended Reading

Are higher rifampin doses for pulmonary TB more effective?
MDedge Infectious Disease
MDedge Daily News: Why low-calorie sucralose may fuel weight gain
MDedge Infectious Disease
Zika virus: Sexual contact risk may be limited to short window
MDedge Infectious Disease
Piperacillin-tazobactam tripled risk of death for patients with cephalosporin-resistant septicemia
MDedge Infectious Disease
FDA advisory committee votes to recommend first once-daily aminoglycoside antibiotic
MDedge Infectious Disease
Don’t shorten therapy for older, sicker cellulitis patients
MDedge Infectious Disease
Study: No link between non-Hodgkin lymphoma and Q fever
MDedge Infectious Disease
Blood type A linked to more-severe diarrhea
MDedge Infectious Disease
NIH launches early Ebola treatment trial
MDedge Infectious Disease
FDA issues Ebola preparedness statement
MDedge Infectious Disease